Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ophthalmic drugs are extensively used to treat glaucoma, cataract, and other ophthalmic disorders. The introduction of new ocular drug delivery methods on the market has led manufacturers to develop innovative treatments for the treatment of ophthalmic diseases.
The prevalence of eye-related diseases and disorders, as well as the incidence of chronic diseases affecting vision, such as neurovascular disease or diabetes, is increasing. The global Ophthalmic Drugs market is expected to register 5.3% CAGR during the forecast period of 2020 to 2026.
The main factors contributing to the growth of the Ophthalmic Drugs market include the increase in the incidence and prevalence of ocule-related diseases, the increase in research and development activities related to the development of new drugs and the increasing focus on the development of combination therapies. Additionally, the increasing investments in developing novel drugs and an increase in the funding for research on ophthalmic drugs are driving the Ophthalmic Drugs market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Ophthalmic Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Ophthalmic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Ophthalmic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bausch and Lomb
Allergan
Valeant Pharmaceuticals
Pfizer
Genentech
Actavis Generics
Johnson and Johnson
Novartis
Santen Pharmaceutical
Shire
Regeneron Pharmaceuticals
Sun Pharmaceutical Industries
By Type:
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
By End-User:
Hospital
Clinic
Pharmacy
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Ophthalmic Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Ophthalmic Drugs Market Size and Growth Rate of Anti-allergy from 2016 to 2027
-
1.3.2 China Ophthalmic Drugs Market Size and Growth Rate of Anti-VEGF Agents from 2016 to 2027
-
1.3.3 China Ophthalmic Drugs Market Size and Growth Rate of Anti-inflammatory from 2016 to 2027
-
1.3.4 China Ophthalmic Drugs Market Size and Growth Rate of Anti-glaucoma from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Ophthalmic Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Ophthalmic Drugs Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 China Ophthalmic Drugs Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Ophthalmic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Ophthalmic Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Anti-allergy
-
3.4.2 Market Size and Growth Rate of Anti-VEGF Agents
-
3.4.3 Market Size and Growth Rate of Anti-inflammatory
-
3.4.4 Market Size and Growth Rate of Anti-glaucoma
4 Segmentation of Ophthalmic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Ophthalmic Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Ophthalmic Drugs in Hospital
-
4.4.2 Market Size and Growth Rate of Ophthalmic Drugs in Clinic
-
4.4.3 Market Size and Growth Rate of Ophthalmic Drugs in Pharmacy
5 Market Analysis by Regions
-
5.1 China Ophthalmic Drugs Production Analysis by Regions
-
5.2 China Ophthalmic Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Ophthalmic Drugs Landscape Analysis
-
6.1 North China Ophthalmic Drugs Landscape Analysis by Major Types
-
6.2 North China Ophthalmic Drugs Landscape Analysis by Major End-Users
7 Central China Ophthalmic Drugs Landscape Analysis
-
7.1 Central China Ophthalmic Drugs Landscape Analysis by Major Types
-
7.2 Central China Ophthalmic Drugs Landscape Analysis by Major End-Users
8 South China Ophthalmic Drugs Landscape Analysis
-
8.1 South China Ophthalmic Drugs Landscape Analysis by Major Types
-
8.2 South China Ophthalmic Drugs Landscape Analysis by Major End-Users
9 East China Ophthalmic Drugs Landscape Analysis
-
9.1 East China Ophthalmic Drugs Landscape Analysis by Major Types
-
9.2 East China Ophthalmic Drugs Landscape Analysis by Major End-Users
10 Northeast China Ophthalmic Drugs Landscape Analysis
-
10.1 Northeast China Ophthalmic Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Ophthalmic Drugs Landscape Analysis by Major End-Users
11 Southwest China Ophthalmic Drugs Landscape Analysis
-
11.1 Southwest China Ophthalmic Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Ophthalmic Drugs Landscape Analysis by Major End-Users
12 Northwest China Ophthalmic Drugs Landscape Analysis
-
12.1 Northwest China Ophthalmic Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Ophthalmic Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bausch and Lomb
-
13.1.1 Bausch and Lomb Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Allergan
-
13.2.1 Allergan Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Valeant Pharmaceuticals
-
13.3.1 Valeant Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Pfizer
-
13.4.1 Pfizer Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Genentech
-
13.5.1 Genentech Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Actavis Generics
-
13.6.1 Actavis Generics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Johnson and Johnson
-
13.7.1 Johnson and Johnson Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis
-
13.8.1 Novartis Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Santen Pharmaceutical
-
13.9.1 Santen Pharmaceutical Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Shire
-
13.10.1 Shire Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Regeneron Pharmaceuticals
-
13.11.1 Regeneron Pharmaceuticals Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Sun Pharmaceutical Industries
-
13.12.1 Sun Pharmaceutical Industries Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Anti-allergy from 2016 to 2027
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Anti-VEGF Agents from 2016 to 2027
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Anti-inflammatory from 2016 to 2027
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Anti-glaucoma from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Ophthalmic Drugs Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Ophthalmic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Ophthalmic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Ophthalmic Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Ophthalmic Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Ophthalmic Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Anti-allergy
-
Figure Market Size and Growth Rate of Anti-VEGF Agents
-
Figure Market Size and Growth Rate of Anti-inflammatory
-
Figure Market Size and Growth Rate of Anti-glaucoma
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Ophthalmic Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Ophthalmic Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Pharmacy
-
Table China Ophthalmic Drugs Production by Regions
-
Table China Ophthalmic Drugs Production Share by Regions
-
Figure China Ophthalmic Drugs Production Share by Regions in 2016
-
Figure China Ophthalmic Drugs Production Share by Regions in 2021
-
Figure China Ophthalmic Drugs Production Share by Regions in 2027
-
Table China Ophthalmic Drugs Consumption by Regions
-
Table China Ophthalmic Drugs Consumption Share by Regions
-
Figure China Ophthalmic Drugs Consumption Share by Regions in 2016
-
Figure China Ophthalmic Drugs Consumption Share by Regions in 2021
-
Figure China Ophthalmic Drugs Consumption Share by Regions in 2027
-
Table North China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table North China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure North China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure North China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table North China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure North China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure North China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table Central China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table Central China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure Central China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure Central China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table Central China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure Central China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure Central China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table South China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table South China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure South China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure South China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table South China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure South China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure South China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table East China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table East China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure East China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure East China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table East China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure East China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure East China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure Northeast China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure Northeast China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table Northeast China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure Southwest China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure Southwest China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table Southwest China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Ophthalmic Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Ophthalmic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Ophthalmic Drugs Consumption Share by Types in 2016
-
Figure Northwest China Ophthalmic Drugs Consumption Share by Types in 2021
-
Figure Northwest China Ophthalmic Drugs Consumption Share by Types in 2027
-
Table Northwest China Ophthalmic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Ophthalmic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Ophthalmic Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Ophthalmic Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Ophthalmic Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bausch and Lomb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch and Lomb
-
Figure Sales and Growth Rate Analysis of Bausch and Lomb
-
Figure Revenue and Market Share Analysis of Bausch and Lomb
-
Table Product and Service Introduction of Bausch and Lomb
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Valeant Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals
-
Table Product and Service Introduction of Valeant Pharmaceuticals
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Actavis Generics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Generics
-
Figure Sales and Growth Rate Analysis of Actavis Generics
-
Figure Revenue and Market Share Analysis of Actavis Generics
-
Table Product and Service Introduction of Actavis Generics
-
Table Company Profile and Development Status of Johnson and Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson
-
Figure Sales and Growth Rate Analysis of Johnson and Johnson
-
Figure Revenue and Market Share Analysis of Johnson and Johnson
-
Table Product and Service Introduction of Johnson and Johnson
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Santen Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santen Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Santen Pharmaceutical
-
Figure Revenue and Market Share Analysis of Santen Pharmaceutical
-
Table Product and Service Introduction of Santen Pharmaceutical
-
Table Company Profile and Development Status of Shire
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire
-
Figure Sales and Growth Rate Analysis of Shire
-
Figure Revenue and Market Share Analysis of Shire
-
Table Product and Service Introduction of Shire
-
Table Company Profile and Development Status of Regeneron Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals
-
Table Product and Service Introduction of Regeneron Pharmaceuticals
-
Table Company Profile and Development Status of Sun Pharmaceutical Industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries
-
Table Product and Service Introduction of Sun Pharmaceutical Industries
-
